Serum Peptidomic Profile as a Novel Biomarker for Rheumatoid Arthritis

Area of Science:

• Biochemistry
• Immunology
• Proteomics

Background:

• Current rheumatoid arthritis (RA) diagnostics rely on serologic biomarkers, necessitating discovery of new markers for early diagnosis and treatment response.
• There is a growing need for advanced diagnostic tools beyond traditional serological methods for RA management.

Purpose of the Study:

• To analyze the serum peptidomic profile in rheumatoid arthritis (RA) patients using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS).
• To identify novel serum protein biomarkers for differentiating RA from osteoarthritis (OA) and healthy controls (HC).

Main Methods:

• Serum peptidomic profiling was performed on 35 RA patients, 35 OA patients (disease control), and 35 healthy controls (HC).
• Magnetic bead (MB) separation coupled with MALDI-TOF-MS was employed for serum analysis.
• Genetic algorithm (GA) models were utilized to assess the diagnostic performance of identified peaks.

Main Results:

• The analysis revealed distinct peptidomic profiles differentiating RA from OA (113 peaks) and RA from HC (101 peaks).
• Significant differences were also observed between OA and HC (38 significant peaks, p < 0.05).
• The GA model demonstrated high sensitivity and specificity across all comparisons (RA vs. HC, OA vs. HC, RA vs. OA).

Conclusions:

• Serum peptidomic patterns are valuable for distinguishing individuals with RA from those with OA and healthy controls.
• MALDI-TOF-MS combined with MB separation is an effective technique for identifying novel serum protein biomarkers associated with RA.